AMA eyes campaign to halt pathology bulk-billing cuts

THE AMA is considering a campaign to stop the slashing of pathology bulk-billing incentives announced without warning in December.

AMA president Professor Brian Owler says the government has failed to understand the impact of the proposed cuts to pathology and diagnostic-imaging bulk-billing incentives, a cost-saving included in the mid-year economic and fiscal outlook (MYEFO).

Patients will be hit with substantially increased costs for diagnostic tests, and pathology collection centres will be forced to close, he says.